Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase

FEBS Letters

Volumn 438, Issue 3, 1998, Pages 201-205

  Oscarson, Mikael ^a   Gullstén, Harriet ^b   Rautio, Arja ^b   Bernal, Maria Luisa ^c   Sinues, Blanca ^c   Dahl, Marja Liisa ^d   Stengård, Jari H ^e   Pelkonen, Olavi ^b   Raunio, Hannu ^b   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d Dept of Med Lab Sci and T ^*  (Sweden)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Allele; Coumarin; Cytochrome P450; Genotype; Methoxyflurane; Phenotype

Indexed keywords

CYTOCHROME C OXIDASE; CYTOCHROME P450; NICOTINE;

ALLELE; ARTICLE; FINLAND; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; SMOKING; SPAIN; SWEDEN;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FINLAND; GENOTYPE; HUMANS; MIXED FUNCTION OXYGENASES; OXIDOREDUCTASES; PHENOTYPE; POLYMERASE CHAIN REACTION; SMOKING; SPAIN; SWEDEN; TOBACCO USE DISORDER;

EID: 0031737551     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01297-6     Document Type: Article

References (41)

1. Ingelman-Sundberg M. Arch. Toxicol. Suppl. 19:1997;3-13.
2. Raunio H., Husgafvel-Pursiainen K., Anttila S., Hietanen E., Hirvonen A., Pelkonen O. Gene. 159:1995;113-121.
3. Yamano S., Tatsuno J., Gonzalez F.J. Biochemistry. 29:1990;1322-1329.
4. Yun C.H., Shimada T., Guengerich F.P. Mol. Pharmacol. 40:1991;679-685.
5. Gonzalez F.J., Gelboin H.V. Drug Metab. Rev. 26:1994;165-183.
6. Crespi C.L., Penman B.W., Leakey J.A., Arlotto M.P., Stark A., Parkinson A., Turner T., Steimel D.T., Rudo K., Davies R.L., Langenbach R. Carcinogenesis. 11:1990;1293-1300.
7. Yamazaki H., Inui Y., Yun C.H., Guengerich F.P., Shimada T. Carcinogenesis. 13:1992;1789-1794.
8. Kharasch E.D., Hankins D.C., Thummel K.E. Anesthesiology. 82:1995;689-699.
9. Spracklin D.K., Hankins D.C., Fisher J.M., Thummel K.E., Kharasch E.D. J. Pharmacol. Exp. Ther. 281:1997;400-411.
10. Nunoya K., Yokoi Y., Kimura K., Kodama T., Funayama M., Inoue K., Nagashima K., Funae Y., Shimada N., Green C., Kamataki T. J. Pharmacol. Exp. Ther. 277:1996;768-774.
11. Torchin C.D., McNeilly P.J., Kapetanovic I.M., Strong J.M., Kupferberg H.J. Drug Metab. Dispos. 24:1996;1002-1008.
12. Wirz B., Valles B., Parkinson A., Madan A., Probst A., Zimmerlin A., Gut J. ISSX Proc. 10:1996;359.
13. Sadeque A.J.M., Fisher M.B., Korzekwa K.R., Gonzalez F.J., Rettie A.E. J. Pharmacol. Exp. Ther. 283:1997;698-703.
14. Madan A., Parkinson A., Faiman M.D. Drug Metab. Dispos. 23:1995;1153-1162.
15. Messina E.S., Tyndale R.F., Sellers E.M. J. Pharmacol. Exp. Ther. 282:1997;1608-1614.
16. Cashman J.R., Park S.B., Yang Z.C., Wrighton S.A., Jacob P., Benowitz N.L. Chem. Res. Toxicol. 5:1992;639-646.
17. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. Drug Metab. Dispos. 24:1996;1212-1217.
18. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. J. Pharmacol. Exp. Ther. 277:1996;1010-1015.
19. Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Pharmacogenetics. 2:1992;227-233.
20. Cholerton S., Idle M.E., Vas A., Gonzalez F.J., Idle J.R. J. Chromatogr. 575:1992;325-330.
21. Iscan M., Rostami H., Iscan M., Guray T., Pelkonen O., Rautio A. Eur. J. Clin. Pharmacol. 47:1994;315-318.
22. Shimada T., Yamazaki H., Guengerich F.P. Xenobiotica. 26:1996;395-403.
23. Camus A.M., Geneste O., Honkakoski P., Bereziat J.C., Henderson C.J., Wolf C.R., Bartsch H., Lang M.A. Mol. Carcinogen. 7:1993;268-275.
24. Daly A.K., Brockmöller J., Broly F., Eichelbaum M., Evans W.E., Gonzalez F.J., Huang J.D., Idle J.R., Ingelman-Sundberg M., Ishizaki T., Jacqz-Aigrain E., Meyer U.A., Nebert D.W., Steen V.M., Wolf C.R., Zanger U.M. Pharmacogenetics. 6:1996;193-201.
25. Hadidi H., Zahlsen K., Idle J.R., Cholerton S. Food Chem. Toxicol. 35:1997;903-907.
26. Fernandez-Salguero P., Hoffman S.M., Cholerton S., Mohrenweiser H., Raunio H., Rautio A., Pelkonen O., Huang J.D., Evans W.E., Idle J.R., Gonzalez F.J. Am. J. Hum. Genet. 57:1995;651-660.
27. Nunoya K., Yokoi T., Kimura K., Inoue K., Kodama T., Funayama M., Nagashima K., Funae Y., Green C., Kinoshita M., Kamataki T. Pharmacogenetics. 8:1998;239-249.
28. Gullstén H., Agúndez J.A., Benítez J., Laara E., Ladero J.M., Diaz-Rubio M., Fernandez-Salguero P., Gonzalez F., Rautio A., Pelkonen O., Raunio H. Pharmacogenetics. 7:1997;247-250.
29. Dahl M.L., Johansson I., Porsmyr Palmertz M., Ingelman-Sundberg M., Sjöqvist F. Clin. Pharmacol. Ther. 51:1992;12-17.
30. Bernal, M.L., Sinues, B., Johansson, I., McLellan, R.A., Dahl, M.-L., Ingelman-Sundberg, M. and Bertilsson, L. (1998) submitted.
31. Vartiainen E., Puska P., Jousilahti P., Korhonen H.J., Tuomilehto J., Nissinen A. Int. J. Epidemiol. 23:1994;495-504.
32. Pasanen M., Rannala Z., Tooming A., Sotaniemi E.A., Pelkonen O., Rautio A. Toxicology. 123:1997;177-184.
33. Cheng S., Fockler C., Barnes W.M., Higuchi R. Proc. Natl. Acad. Sci. USA. 91:1994;5695-5699.
34. Miles J.S., Bickmore W., Brook J.D., McLaren A.W., Meehan R., Wolf C.R. Nucleic Acids Res. 17:1989;2907-2917.
35. Ding S., Lake B.G., Friedberg T., Wolf C.R. Biochem. J. 306:1995;161-166.
36. Hoffman S.M., Fernandez-Salguero P., Gonzalez F.J., Mohrenweiser H.W. J. Mol. Evol. 41:1995;894-900.
37. Barnes W.M. Trends Biochem. Sci. 19:1994;342.
38. Dahl M.L., Bertilsson L. Pharmacogenetics. 3:1993;61-70.
39. Eichelbaum M., Evert B. Clin. Exp. Pharmacol. Physiol. 23:1996;983-985.
40. Benowitz N.L., Jacob P. III. NIDA Res. Monogr. 173:1997;48-64.
41. Pianezza M.L., Sellers E.M., Tyndale R.F. Nature. 393:1998;750.